The Promise of Partial Cellular Reprogramming For twenty years, researchers have known how to reset a cell’s internal clock ...
BOSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Life Biosciences ("Life Bio"), a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging, today ...
Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy designed to reverse cellular aging in the human eye. The trial, registered as ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results